Pills to wellness, Cipla is seeking a new identity
Drugmaker Cipla wants to be more than just a pharmaceutical company selling a pill and aims to play a bigger role in a patient’s journey...
Continue ReadingAurobindo Pharma gets USFDA nod for generic cancer drug Bortezomib
“Bortezomib for injection is indicated for the treatment of adult patients with multiple myeloma (cancer of plasma cells) and is also used to treat adult...
Continue ReadingJulphar to launch over 100 new medicines as part of growth strategy
DUBAI: Gulf Pharmaceutical Industries Julphar has announced its Strategy 2030, an effort to drive transformation that will contribute to higher shareholder returns.According to the Emirates...
Continue ReadingWHO ‘strongly recommends’ Pfizer’s Covid pill
For the same patients, the WHO also made a “conditional (weak) recommendation” of the antiviral drug remdesivir made by US biotech firm Gilead — which...
Continue ReadingNutraceutical manufacturing, the complex process simplified through vertical integration.
According to the October 2021 report by the US-based Grand View Research, the global nutraceutical market is projected to reach $8,26,426.3 million by 2028, expanding...
Continue ReadingCadila Pharma launches world’s first novel three-dose rabies vaccine ThRabis
In an important breakthrough, pharma major Cadila Pharmaceuticals has developed a novel three-dose recombinant nano-particle-based rabies G protein vaccine, ThRabis. Aiming at a Rabies-Free India,...
Continue ReadingModerna launches clinical trials of flu vaccines using mRNA technology deployed in Covid jabs
Moderna today began clinical trials for a flu shot that uses the same mRNA technology deployed in COVID-19 vaccines. The Massachusetts-based firm said a single...
Continue ReadingBlockchain could solve pharma’s supply chain challenges, says Zuellig Pharma
Daniel Laverick is VP and Head of Digital & Data at Zuellig Pharma, one of the largest healthcare companies in Asia. Ahead of his session...
Continue ReadingBiocon Biologics gets European Medicines Agency’s backing for Inpremzia
Biocon Biologics, an arm of Biocon Ltd, said a committee of the European Medicines Agency has recommended the granting of marketing authorisation for its biosimilar,...
Continue Reading